News
Riverlane, ColdQuanta and University of Wisconsin–Madison Achieve Multi-Qubit Entanglement and Algorithms on a Programmable Neutral Atom Quantum Computer
Joe Donlan, Scientific Writer
Why cracking quantum error correction is the key that will unlock quantum computing
Jake Taylor, Chief Science Officer
Riverlane leads UK consortium to build auto-calibrated quantum control system ‘Deltaflow Control’
Amy Flower, Communications Associate
From Von Neumann to systems engineering: what quantum can learn from classical computing
Steve Brierley, Founder and CEO
Enabling the hydrogen economy through quantum computing
Joe Donlan, Scientific Writer
Riverlane appoints leading scientist Dr. Earl Campbell to accelerate efforts to solve quantum error correction
Amy Flower, Communications Associate
Riverlane joins £7.5 million consortium to build error corrected quantum processor
Joe Donlan, Scientific Writer
Riverlane convenes panel of world-leading experts on quantum error correction
Joe Donlan, Scientific Writer
Designing better catalysts with quantum computers
Joe Donlan, Scientific Writer
Riverlane appoints Glenn Manoff as Chief Marketing Officer
Amy Flower, Communications Associate
Riverlane appoints Cory Vander Jagt as Vice President of Business Development and Strategic Alliances
Amy Flower, Communications Associate
How quantum computing can help tackle climate change
Steve Brierley, Founder and CEO
Riverlane appoints eminent quantum physicist Jake Taylor as Chief Science Officer
Amy Flower, Communications Associate
Riverlane featured in The Telegraph
Amy Flower, Communications Associate
A major step towards the world’s first universal quantum operating system
Marco Ghibaudi, VP Engineering
Riverlane awarded the first contract to supply quantum software to the UK’s National Quantum Computing Centre
Amy Flower, Communications Associate
Celebrating the first five years of Riverlane: a look at how far we’ve come
Steve Brierley, Founder and CEO
Riverlane and Astex Pharmaceuticals join forces with Rigetti Computing to drive drug discovery forward
Amy Flower, Communications Associate
